Corvus Pharmaceuticals Inc buy Cantor Fitzgerald
Start price
01.04.24
/
50%
€1.67
Target price
01.04.25
-
Performance (%)
129.39%
Price
22.08.24
€3.67
Summary
This prediction is currently active. With a performance of 129.39% the BUY prediction by Cantor_Fitzgerald is a big success. This prediction currently runs until 01.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Corvus Pharmaceuticals Inc | 7.636% | 7.636% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.51
07.09.23
07.09.23
€3.74
07.09.24
07.09.24
154.30%
22.08.24
22.08.24